YENO is a leading company in the field of applied epigenetics, specializing in the regulation of cell communication by harnessing cell intelligence. After years of research, YENO has developed methods for rapid, efficient, and targeted epigenetic regulation of immune modulation, supported by in vitro and application studies.
Using the patented GENOS process, YENO developed the signal transduction molecule RM31 , which, through epigenetic regulation, rapidly improves the immune response, particularly of CD4 and CD8 T cells and natural killer cells (NK cells). This led to the development of the prescription drug GENOS Immune Plus, which enables rapid and targeted modulation of the immune system and can be easily combined with other therapies. The term cellular intelligence refers to the ability of our body's cells to process information, respond to stimuli, and adapt to changing conditions. Cell communication plays an important role in this. Cell communication is therefore a key component in the regulation of diseases.
Epigenetic & Cell Intelligence
as a solution
the innovativ epigenetic modulation therapy for an optimized immune system
Immunomodulation
through corrected cell communication
Signal transduction molecules, the messengers of cell communication, are crucial for the transmission of signals within cells and enable them to respond to various stimuli. GENOS Immune Plus is a novel epigenetic application that modulates the immune system in a targeted, rapid, and, according to current knowledge, side-effect-free manner.
The signal transduction molecule RM31 contained in the product improves cell communication and represents a significant innovation in medicine to address current immunological challenges.
RM31
the key molecule
RM31 is a natural, organic key molecule found in all body cells. It plays a central role in cell communication, particularly in signal transduction and immune response, and positively influences numerous epigenetic and autocatalytic processes.
The research and application results of GENOS Immune Plus demonstrate that the signal transduction molecule RM31 enhances the immune modulation of CD4 and CD8 T cells, as well as NK cells. This is achieved through epigenetic regulation of S1P receptor function via RM31-induced phosphorylation. For detailed information, please visit our department.
Application
Each GENOS IMMUNE PLUS READY-TO-USE box contains 12 vials of 7.0 ml of RM31. We recommend administering 7.0 ml intravenously 2-3 times per week, with a 2-day interval between doses, without dilution, directly into a vein. An intravenous dose of 300 µg selenium 10 minutes before administration may have a positive effect on immune modulation.
Approval according to
§ 21 AMG
GENOS IMMUNE PLUS is a high-quality, extemporaneous prescription drug approved under Section 21 of the German Medicines Act (AMG) . It is manufactured in Germany according to the strictest GMP regulations and tested for sterility and quality by an external laboratory.
Manufactured in the pharmacy using the patented YENO QUANTUM ONE laboratory device, which enables epigenetically effective signal transduction of the RM31 molecule (signal transduction molecule). After 72 hours of epigenetic activation, GENOS IMMUNE PLUS has a shelf life of 6-8 weeks.
A notice!
The preservative-free injection solution is intended for single use only per 7.0 ml vial. It must be used immediately after opening the vial. Any unused portion should be discarded. Do not store the vials above 25°C and protect them from light. Please ensure that no direct cell phone radiation (electromagnetic radiation) comes near (50 cm away) the vial, as this may reduce or negate its effectiveness. To prevent radiation damage, the ampoules are wrapped in a radiation-protective cloth. Please store the ampoules in the protective cloth.
GENOS IMMUNE PLUS “READY TO USE BOX”
GENOS IMMUNE PLUS 12 x 7.0 ml vials
Please contact us at info@genos-immune.com to receive your login details as a GENOS physician. You can then register as a GENOS practitioner. After registration, you will receive access to the ordering process at the manufacturer's pharmacy. The use of GENOS Immune Plus medications is reserved exclusively for YENO-trained professionals.
Because GENOS IMMUNE PLUS is an epigenetic application, YENO places the highest priority on understanding its regulatory function and ensuring safety of use by its practitioners. Yeno therefore provides a free introduction to GENOS users to provide information on application safety, applied epigenetics, and the use of RM31 as a signal transduction molecule.
GENOS PARTNERS (doctors, therapists and clinics)
More GENOS products......
